38912711000001102: Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\UK product\Virtual medicinal product\Generic Kaftrio 75mg/50mg/100mg tablets\Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\UK product\Virtual therapeutic moiety\Ivacaftor + Tezacaftor + Elexacaftor\Generic Kaftrio 75mg/50mg/100mg tablets\Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\UK product\Trade family\Kaftrio\Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing cystic fibrosis transmembrane conductance regulator potentiator\Product containing ivacaftor\Product containing ivacaftor and tezacaftor (medicinal product)\Product containing elexacaftor and ivacaftor and tezacaftor (medicinal product)\Ivacaftor + Tezacaftor + Elexacaftor\Generic Kaftrio 75mg/50mg/100mg tablets\Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing quinoline\Product containing ivacaftor\Product containing ivacaftor and tezacaftor (medicinal product)\Product containing elexacaftor and ivacaftor and tezacaftor (medicinal product)\Ivacaftor + Tezacaftor + Elexacaftor\Generic Kaftrio 75mg/50mg/100mg tablets\Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

144261000001116 Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

144271000001114 Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Is a	Generic Kaftrio 75mg/50mg/100mg tablets	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator	EMA (European Medicines Agency) monitoring	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Is a	Kaftrio	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has specific active ingredient	Ivacaftor	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has specific active ingredient	Tezacaftor	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	VMP prescribing status (attribute)	Never valid to prescribe as a VMP	true	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has specific active ingredient	Elexacaftor	false	Inferred relationship	Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has specific active ingredient	Elexacaftor	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets	Has AMP	True	Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
144261000001116	Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
144271000001114	Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module